Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 4.52 Billion |
| USD 7.60 Billion | |
| % | |
|
Global Serological Testing Market, By Test Type (Primary Serological Tests, Secondary Serological Tests, Tertiary Binding Tests), Application (Rotavirus Infections, Hepatitis, HIV, Endotoxins, Therapeutic Drug Monitoring, Other Infectious Diseases), End Users (Hospitals, Diagnostic Laboratories, Blood Banks, Academic and Research Institutes, Others), End User (Hospital and Clinics, Diagnostic Laboratories, Others) – Industry Trends and Forecast to 2030.
Get Exclusive Sample Copy of this Report Here
In 2019, as per the Centers for Diseases Control and Prevention, approximately 34,800 new HIV cases were registered in the U.S. Different serology tests are used to identify antibodies or antigens. Some of the most vital applications for the solutions and products that the market players in the market develop include rotavirus infections, therapeutic drug monitoring, HIV, hepatitis, endotoxins, and other infectious diseases.
Data Bridge Market Research analyses that the serological testing market is expected to reach USD 7.6 billion by 2030, which is USD 4.52 billion in 2022, and is expected to undergo a CAGR of 6.70% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Test Type (Primary Serological Tests, Secondary Serological Tests, Tertiary Binding Tests), Application (Rotavirus Infections, Hepatitis, HIV, Endotoxins, Therapeutic Drug Monitoring, Other Infectious Diseases), End Users (Hospitals, Diagnostic Laboratories, Blood Banks, Academic and Research Institutes, Others), End User (Hospitals, Trauma Centres, Ambulatory Surgical Centres and Other)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Serological Research Institute (SERI) (U.K.), Chembio Diagnostics, Inc (U.S.), Cellex (U.S.), Randox Laboratories Ltd (U.K.), Abbott (U.S.), Bio-Rad Laboratories Inc. (U.S.), BD (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Ortho Clinical Diagnostics (U.S.), Quest Diagnostics Incorporated (U.S), Abcam Plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), ELITechGroup (France), Teleflex Incorporated (U.S.), Grifols, S.A. (U.S.), Global Scientific Company(India), Beckman Coulter, Inc. (U.S.), BIOMEDOMICS INC. (U.S.), Creative Diagnostics (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Serology tests are used to identify antibodies or antigens. When the body comes in contact with an antigen, the immune system releases antibodies as a defense mechanism and tries to normalize the antigen. In serological testing, such antigens and antibodies are validated for the diagnosis of a specific disease and condition that further helps doctors give proper medical treatment. Serology testing is done by numerous methods such as enzyme-linked immunosorbent assays (ELISAs), hemagglutinin-inhibition tests, flocculation tests, chemiluminescence immunoassays and neutralization tests
Drivers
The market is witnessing a major shift away from the traditional ELISA method and moving towards the use of CLIA. Disease complications have surged the need to detect smaller target molecules, which leads to the emergence of CLIA. It is used in combination with a directly labelling antigen (antibody) and an indicator such as isoluminol, luminol, or an acridinium ester. The increasing sensitivity and accuracy of chemiluminescence immunoassay over enzyme-linked immunosorbent assay (ELISA) is anticipated to drive the market growth.
The antibody test contributes to the market growth. This dominance is due to the benefits of antibody tests and several advancements in the testing of the serological virus. The high demand for other tests such as viral load tests, genotype tests are going to increase in the forecast period because of the improvements and test accuracies and adoption by expert professionals.
Opportunities
ELISA is of great demand and leading the market due to less turnaround time for testing, long self-life of regents, cheap and affordable reagents, a high number of infectious diseases screenings, high specificity, high sensitivity, and ELISA analyzers are inexpensive. Moreover, technological advancement, less complex steps required for performing, high precision screening, and many several key players are contributing to the growth of ELISA testing segment.
There has been increasing incidence of TB in the recent years that lead to the growth of the serological testing. India's TB incidence for the year 2021 is 210 per 100,000 population than the baseline year of 2015. The incidence was 256 per lakh of population in India and there has been an 18% deterioration. TB is the 13th leading cause of death worldwide and the second leading cause of infectious killer after COVID-19.
Restraints/Challenges
There has been numerous tests that are hugely available for testing hepatitis diseases. But these tests are of increasing cost that is not afforded by numerous patients, mainly belonging to the lower economic groups. Thus, it hampers the market growth.
This serological testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the serological testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
The serological testing market is segmented on the basis of test type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
Application
End-user
The serological testing market is analyzed and market size insights and trends are provided by test type, application and end-user as referenced above.
The countries covered in the serological testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the serological testing market due to the increasing incidence of infectious diseases, well-established health care infrastructure and rise in number of geriatric population in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the increase in awareness, and rise in per capita health care expenditure along with huge rate of infectious diseases in developing countries such as India and China.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The serological testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for serological testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the serological testing market. The data is available for historic period 2011-2021.
The serological testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to serological testing market.
Some of the major players operating in the serological testing market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.